Healthcare AI Readiness Assessment
Seven questions cover the infrastructure, governance, and change-management foundations most healthcare orgs need before rolling out AI at scale. Takes under a minute.
Generic AI readiness tools miss what matters in clinical deployment
Microsoft, Cisco, Deloitte, and PwC all publish AI readiness frameworks. They're useful for enterprise IT in general. They're also too generic to surface the failure modes specific to healthcare AI: FHIR availability, HIPAA SRA currency, clinical champions, de-identification pipelines. The 7 dimensions below are each drawn from real pilots that stalled on them.
Take the assessment
Answer all 7 questions. Your score, tier, and tailored recommendations appear at the bottom. No email required.
- Do you have FHIR R4 APIs available in production?
- Is your integration engine (Mirth, Rhapsody, Iguana, etc.) in production with documented interfaces?
- Do you have a current HIPAA security risk assessment (within the last 12 months)?
- Is there an identified clinical champion who will lead AI adoption in your org?
- Do you have a de-identification pipeline for patient data used in analytics or model training?
- Is there a documented vendor evaluation + security review process for new software?
- Does your organization have capacity to run a workflow change pilot in the next 6 months?
What each question is really measuring
Every dimension maps to a specific failure mode we've seen stall AI pilots. Here's why each matters, what good looks like, and how things go wrong.
1. FHIR R4 API availability
Why it matters: FHIR is the lingua franca of modern healthcare interoperability and the default integration surface for most AI vendors.
What good looks like: Production FHIR R4 endpoints with at least Patient, Encounter, Observation, DocumentReference, and MedicationRequest resources. SMART on FHIR launch framework available for embedded apps.
Failure mode: AI pilots stall waiting for FHIR enablement — typically 3-6 months of delay. Some vendors will fall back to HL7 v2 but with significantly reduced functionality.
2. Integration engine maturity
Why it matters: Even with FHIR, real deployments require an integration engine to orchestrate message flow, apply transforms, and handle the long tail of non-FHIR systems (ADT feeds, billing, lab, pharmacy).
What good looks like: Production Mirth Connect, Rhapsody, Iguana, Corepoint, or equivalent with a documented interface inventory. Dedicated integration team (or partner) to maintain and extend interfaces.
Failure mode: AI vendors request an interface inventory in week 1 of the engagement. If nobody can produce one, the integration scope becomes unbounded and the timeline doubles.
3. HIPAA security risk assessment (current)
Why it matters: Most AI vendor Business Associate Agreements require a current Security Risk Assessment as a prerequisite. An outdated SRA blocks contract signing even when everything else is green.
What good looks like: SRA completed or refreshed within the last 12 months, with findings tracked to remediation. Documented policies for encryption, access control, audit logging, breach notification.
Failure mode: Contract review grinds to a halt at the BAA stage. Health systems often have a general SRA but lack specific coverage for AI/ML data flows (training data, model outputs, de-identified data).
4. Clinical champion identification
Why it matters: Clinician-led AI rollouts succeed; IT-led rollouts stall. A named physician or nursing champion provides the clinical credibility, workflow expertise, and peer-to-peer advocacy that determines whether the tool actually gets used.
What good looks like: A specific physician or APP has been identified, has formal time allocation (often 0.1-0.2 FTE), and participates in vendor selection and pilot design.
Failure mode: AI tool deploys but adoption plateaus at 20-40% of licensed providers. ROI projections fail to materialize because the math assumed full adoption.
5. De-identification pipeline
Why it matters: Required for model tuning, quality monitoring, analytics, and most vendor QA workflows. Many organizations assume they have de-identification capability but only have manual processes that don’t scale.
What good looks like: Automated pipeline (Philter, OHDSI, custom HIPAA Safe Harbor or Expert Determination method) with documented accuracy metrics. Tested against a labeled dataset.
Failure mode: Any analytics or model-tuning initiative gets blocked at data extraction. Organizations end up with a manual SQL-export-and-redact process that’s slow, error-prone, and not auditable.
6. Vendor evaluation and security review
Why it matters: AI vendors often surface third-party subprocessors (cloud providers, subcontractor models, data-labeling vendors) that each need their own review. A case-by-case process becomes unmanageable by the third vendor.
What good looks like: Documented vendor evaluation workflow covering security, privacy, clinical accuracy, integration fit, and commercial terms. Clear escalation path for edge cases. HITRUST or SOC 2 Type II verified where applicable.
Failure mode: Procurement reinvents the review process for each vendor, burning 6-10 weeks per evaluation. By the time a vendor is approved, the market has moved and the original use case has shifted.
7. Change-management capacity
Why it matters: AI tools change clinician workflow. Organizations running 3 parallel EHR transitions, a merger, and a new scheduling rollout can’t absorb a 4th major change, no matter how good the AI is.
What good looks like: Dedicated change-management function with bandwidth reserved for an AI pilot in the next 6 months. Named clinical transformation leader. Training and communication plan template ready.
Failure mode: Pilot launches but clinicians report "too much change at once." Adoption never stabilizes. The tool is technically deployed but nobody uses it consistently enough to prove value.
What each tier means and what to do next
Score maps to a tier; tier maps to a clear remediation path. Here's what typically happens at each level and how we help.
Early Exploration
Foundations not yet in place. AI deployment is premature — focus on enabling infrastructure first.
What to do next
- Stand up FHIR R4 APIs (Patient, Encounter, Observation, DocumentReference, MedicationRequest)
- Inventory + document integration engine interfaces
- Refresh HIPAA Security Risk Assessment
- Identify clinical champion (physician or APP)
- Run an AI readiness workshop to sequence the next 6 months
Ready to Pilot
Foundations mostly in place with known gaps. Ready to run a tightly scoped pilot while closing gaps in parallel.
What to do next
- Pick ONE use case (ambient scribe is the most common starter)
- Select ONE vendor, ONE department, 90-day timeline
- Define success metrics before pilot launch: adoption rate, time saved, coding accuracy, patient satisfaction delta
- Plan for a second-vendor bake-off to avoid single-vendor lock-in
- Close the readiness gaps flagged in parallel
Production Ready
All foundations in place. Ready for enterprise deployment, multi-vendor orchestration, and ongoing AI operations.
What to do next
- Move from pilot to enterprise deployment
- Evaluate multi-vendor orchestration (most prod AI stacks end up multi-vendor within 18 months)
- Formalize AI model monitoring: drift detection, quarterly clinical reviews
- Build AI-specific incident response runbooks
- Book scaling consultation for cross-department rollout planning
Common Questions
Generic AI readiness assessments (Microsoft, Cisco, Deloitte, PwC) focus on broad organizational capabilities — data strategy, cloud maturity, change management. They’re useful for enterprise IT in general. This one is healthcare-specific: the 7 dimensions cover FHIR R4 APIs, integration engine maturity, HIPAA security risk assessments, clinical champion identification, de-identification pipelines, vendor security review, and clinical change-management capacity. Every dimension maps to a known failure mode in healthcare AI deployments — we’ve seen each one block a pilot first-hand.
That’s by far the most common gap. It doesn’t mean you can’t deploy AI — some vendors integrate via HL7 v2 interfaces or direct database connections — but it does mean you’ll have fewer vendor options, slower deployment timelines, and a higher integration cost. If FHIR is a "no" or "partial," our recommendation is usually to run a focused FHIR API enablement project (Patient, Encounter, Observation, DocumentReference to start) in parallel with vendor evaluation. See our FHIR API Integration services.
No — this assessment is specifically for pre-vendor evaluation. It tells you how ready you are to evaluate vendors at all. If you’re already deep into a specific vendor pilot, you’re past this stage — book a hub-level consultation focused on integration and rollout instead.
The result panel renders live in your browser. Copy the URL or take a screenshot — the score itself isn’t persisted server-side (no sign-in, no email, nothing stored). If you want a durable, shareable report, the "Book a consultation" CTA sends you to a 30-minute call where we walk through your score and generate a written summary for you to share internally.
Most orgs move from Early Exploration (0-40) to Ready to Pilot (41-70) in 6-9 months with a focused foundation program (FHIR APIs + integration engine inventory + HIPAA SRA refresh + clinical champion + vendor eval process). Moving from Ready to Pilot to Production Ready (71-100) takes another 9-18 months and centers on executing 1-2 successful pilots, building de-identification tooling, and formalizing change-management capacity. Health systems that try to compress this faster almost always see their first AI deployment stall at integration, compliance, or clinician adoption.
These are the 7 failure modes we’ve seen block or stall AI deployments across dozens of engagements. We tested a longer 15-question version in early drafts and consolidated it here: the short version hits 90% of the diagnostic value of the long version with 50% of the quiz fatigue. If you want the full 15-dimension deep-dive, that’s what a consultation engagement produces.
Resources
Want to discuss your readiness score?
We'll walk through gap remediation, vendor fit, and a 90-day plan tailored to your org.
- 15 min conversation
- Healthcare IT engineers, not sales
- Reply within one business day
Takes about 90 seconds.